Fund moves

Medtronic (MDT): Advisors Capital Management, LLC added to its stake +53K shares

Advisors Capital Management, LLC added to its stake in Medtronic, per its Q1 2025 13F.

508K
Shares reported · +53K vs prior quarter
0.71%
Disclosed portfolio weight
$45.6M
Reported value
Holdings as of
Mar 31, 2025
Filed
May 27, 2025

What stands out in this filing

  • 454,603 shares in Q4 2024, 507,695 now (+11.7% in share count).
  • Reported at $45.6M, 0.71% of the portfolio value in this 13F filing.
  • 70 other tracked managers reported the same kind of change for Q1 2025.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 15, 2023CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  2. Mar 4, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000
  3. Mar 20, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  4. Mar 24, 2025CongressDisclosed sale of MDT — reported range $50,001 - $100,000
  5. Apr 8, 2025CongressDisclosed sale of MDT — reported range $1,001 - $15,000
  6. May 8, 2025CongressDisclosed sale of MDT — reported range $15,001 - $50,000
  7. May 15, 2025CongressDisclosed purchase of MDT — reported range $1,001 - $15,000

What came next

  1. Jun 20, 2025FDAFDA device clearance: MC2™ Two-Stage Venous Cannula; MC2X™ Three-Stage Venous Cannula
  2. Jun 23, 2025FDARecall: Covidien Nellcor Bedside SpO2 Patient Monitoring System: REF: PM100N, 10005941, DLPM100N, DL10005941, DSPM100N, 10005941-SG, DS10005941, 10005941J, 10005941JP,…
  3. Jun 26, 2025FDAFDA device clearance: The Rialto™ SI Fusion System
  4. Jul 1, 2025FDAFDA device clearance: MiniMed 780G insulin pump
  5. Jul 17, 2025FDARecall: IPC Powerease System REF 2300000 UDI-DI: 00613994448705 00643169406834. The IPC POWEREASE System is indicated for drilling, tapping, and driving screws and wor…
  6. Aug 6, 2025FDAFDA device approval: Simplera Sync Sensor, Guardian 4 Sensor
  7. Aug 6, 2025FDARecall: DLP Left Heart Vent Catheter Malleable body and vented connector, SUCTION 12110 LV VENT 10FR, Model Number 12110
  8. Aug 6, 2025FDARecall: DLP Left Heart Vent Catheter Malleable body and vented connector, SUCTION 12115 LV VENT 15FR, Model Number 12115
  9. Aug 6, 2025FDARecall: DLP Left Heart Vent Catheter Malleable body and vented connector, SUCTION 12113 LV VENT 13FR, Model Number 12113
  10. Aug 14, 2025CongressDisclosed partial sale of MDT — reported range $1,001 - $15,000
  11. Aug 22, 2025InsiderDirector purchased ~$232K of MDT shares in the open market
  12. Aug 25, 2025InsiderDirector purchased ~$231K of MDT shares in the open market
  13. Aug 29, 2025FDAFDA device clearance: SmartGuard technology; Predictive Low Glucose technology
  14. Sep 3, 2025Insider · 1 personInsiders: 2 sales (~$788K)
  15. Sep 4, 2025FDAFDA device clearance: Endoskeleton™ Interbody Systems
  16. Sep 11, 2025FDAFDA device clearance: Mazor X System / Mazor X Stealth Edition
  17. Sep 12, 2025FDARecall: Affinity NT Oxygenator, Oxygenator with Balance Biosurface and Uncoated Cardiotomy/Venous Reservoir, Product Number 541B
  18. Sep 16, 2025FDARecall: Catalyft PL & PL40 Expandable Interbody System labeled as follows with corresponding model numbers: 1. SPACER 6068073 CATALYFT PL SHORT 7MM. Model Number: 6068…
  19. Sep 18, 2025FDAFDA device approval: Medtronic Altaviva System
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Medtronic

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MDT page.

How this filing works

Explore the data

Common questions

What does this filing report about Medtronic (MDT) stock?

Advisors Capital Management, LLC added to its stake in Medtronic, per its Q1 2025 13F. Now 508K shares, $45.6M reported value, 0.71% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2025. Filed: May 27, 2025.

What stands out in this filing?

454,603 shares in Q4 2024, 507,695 now (+11.7% in share count). Reported at $45.6M, 0.71% of the portfolio value in this 13F filing. 70 other tracked managers reported the same kind of change for Q1 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Medtronic recently?

For Medtronic, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the MDT page.

Does this mean MDT stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Medtronic

Everything OQRO holds on this company is on its MDT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data